ENTITY
Pharmaessentia Corp

Pharmaessentia Corp (6446 TT)

124
Analysis
Health Care • Taiwan
PharmaEssentia Corporation develops and distributes therapeutic products for treatment in human disease. The Company develops drugs to treat hepatitis, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myeloid fibrosis (MF), polycythemia vera (PV), hepatitis and cancer.
more
•27 Jul 2026 14:48

Quiddity Leaderboard T50/​​​100 Sep26: TDIV Deletion Names Moving Away from Danger Zone

If the worst-ranked T50 member Alchip (3661 TT) underperforms other names by 1% it could fall to the 61st place and get deleted . In this case,...

Share
•03 Jul 2026 14:44

Quiddity Leaderboard T50/​​​100 Sep26: Getac TDIV Deletion Within Striking Distance

Getac Technology (3005 TT) is fairly close to getting deleted from the T100 index. If it gets deleted from T100, it would also get deleted from...

Share
•01 Jul 2026 14:30

MS-Taiwan Index Earning Revision (Jun): Formosa Plastics, Yang Ming Marine, TSMC, China Steel

We analyzed MS-Taiwan's consensus for Jun 2026 and highlighted changes of EPS in Formosa Plastics, Yang Ming Marine, TSMC, China Development...

Logo
146 Views
Share
•08 Mar 2026 06:11

Quiddity T50/100/TDIV Mar26 Results: 100% Hit Rate; US$1.7bn+ Total One-Way Flows

Yulon Finance (9941 TT) is confirmed as a TDIV DEL because it is a T100 DEL which makes it ineligible for the TDIV index. There could be more than...

Share
•09 Feb 2026 07:10

TWSE Short Interest Weekly (Feb 6th): Jentech Precision Industrial, Realtek Semiconductor

We analyzed TWSE short interest report for the past week and highlighted short interest changes in Jentech Precision Industrial, Realtek...

Logo
261 Views
Share
x